4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GH Research PLC (GHRS) operates in the Biotechnology industry and is headquartered in Dublin, Ireland with about 73 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, GHRS reported $0M in revenue and ($48M) in net income.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($61M) | ($50M) | ($41M) | ($31M) |
| Net Income | ($48M) | ($39M) | ($36M) | ($22M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($19M) | ($17M) | ($16M) | ($15M) | ($13M) | — |
| Net Income | ($19M) | ($14M) | ($14M) | ($9M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $288M | $188M | $226M | $254M | — |
| Total Liabilities | $8M | $9M | $7M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GHRS viewer.
About TickerBase · Data methodology & sources